Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates in cancer therapy.

Jonathan R Green1

  • 1Novartis Pharma AG, Basel, Switzerland. jonathan.green@pharma.novartis.com

Current Opinion in Oncology
|November 1, 2002
PubMed
Summary

Bisphosphonates combat bone metastases by inhibiting osteoclast activity and potentially acting directly on tumor cells. Further research is needed to confirm their antitumor effects and clinical benefits in cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methods for tagging whale sharks: insights into performance and best practices with a focus on clamp attachments.

Animal biotelemetry·2026
Same author

Climate-driven global redistribution of an ocean giant predicts increased threat from shipping.

Nature climate change·2024
Same author

Identifying priority sites for whale shark ship collision management globally.

The Science of the total environment·2024
Same author

Species associated with whale sharks <i>Rhincodontypus</i> (Orectolobiformes, Rhincodontidae) in the Galapagos Archipelago.

Biodiversity data journal·2024
Same author

Diving into the vertical dimension of elasmobranch movement ecology.

Science advances·2022
Same author

Global collision-risk hotspots of marine traffic and the world's largest fish, the whale shark.

Proceedings of the National Academy of Sciences of the United States of America·2022

Area of Science:

  • Oncology
  • Pharmacology
  • Bone Biology

Background:

  • Bisphosphonates are established treatments for metastatic bone disease, primarily by inhibiting osteoclast-mediated bone resorption.
  • Preclinical data suggest complex mechanisms involving bisphosphonates' effects on bone metastases.
  • Nitrogen-containing bisphosphonates target the mevalonate pathway, impacting osteoclast function and inducing apoptosis in osteoclasts and tumor cells.

Purpose of the Study:

  • To explore the multifaceted mechanisms by which bisphosphonates inhibit bone resorption and interfere with bone metastasis.
  • To investigate the direct antitumor effects of bisphosphonates, including cytostatic activity, inhibition of cell adhesion, and invasion.
  • To evaluate the potential clinical benefit of bisphosphonates in cancer patients with bone metastases.

Main Methods:

  • Review of preclinical data on bisphosphonate mechanisms.
  • Analysis of studies on the mevalonate pathway inhibition by nitrogen-containing bisphosphonates.
  • Examination of evidence from animal models regarding skeletal tumor burden reduction.

Main Results:

  • Bisphosphonates inhibit osteoclast function and induce apoptosis in osteoclasts and tumor cells.
  • Evidence shows bisphosphonates possess cytostatic activity and inhibit tumor cell adhesion and invasion.
  • Animal models indicate bisphosphonates can reduce skeletal tumor burden.

Conclusions:

  • The precise mechanisms by which bisphosphonates affect bone metastases require further elucidation.
  • It is unclear if observed reductions in tumor burden are due to direct antitumor effects or indirect osteoclast inhibition.
  • Clinical trials are necessary to determine the therapeutic potential of bisphosphonates against cancer bone metastases.

Related Experiment Videos